John Connor Wells

8PUBLICATIONS
54CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsTraditional Chinese medicine and treatmentsPredictive and prognostic markersChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 02, 2025
Tumor-Intrinsic and Microenvironmental Determinants of Impaired Antitumor Immunity in Chromophobe Renal Cell Carcinoma.

Chris Labaki, Eddy Saad, Katrine N Madsen

|Apr 17, 2024
Impact of smoking status on clinical outcomes in patients with metastatic renal cell carcinoma treated with first-line immune checkpoint inhibitor-based regimens.

Eddy Saad, Georges Gebrael, Karl Semaan

|Mar 11, 2022
Complementary Medicine Use Amongst Patients with Metastatic Cancer Enrolled in Phase III Clinical Trials.

J Connor Wells, Aven Sidhu, Keyue Ding

|Aug 31, 2021
Interactive Data Visualization Tool for Patient-Centered Decision Making in Kidney Cancer.

Kevin Shee, Sumanta K Pal, J Connor Wells

|Apr 30, 2021
Cancer, Clinical Trials, and Canada: Our Contribution to Worldwide Randomized Controlled Trials.

Shubham Sharma, J Connor Wells, Wilma M Hopman

|Jan 19, 2021
Cabozantinib real-world effectiveness in the first-through fourth-line settings for the treatment of metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium.

Chun Loo Gan, Shaan Dudani, J Connor Wells

Pageof 2

Frequent Collaborators

4 joint publications

Toni K Choueiri

2 joint publications

Sumanta K Pal

2 joint publications

Eddy Saad

1 joint publications

Steven M Yip